No black box warning on record for Inrebic

As of the latest FDA labeling reviewed, Inrebic (FEDRATINIB HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Inrebic medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Anemia and Thrombocytopenia: Manage by dose reduction, interruption, or transfusion ( 5.2 ). • Gastrointestinal Toxicity: Manage by dose reduction or interruption if patient develops severe diarrhea, nausea, or vomiting. Prophylaxis with antiemetics and treatment with antidiarrhea medications are recommended ( 5.3 ). • Hepatic Toxicity: Manage by dose reduction or inte

No black box warning on record for Inrebic

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Anemia and Thrombocytopenia: Manage by dose reduction, interruption, or transfusion ( 5.2 ). • Gastrointestinal Toxicity: Manage by dose reduction or interruption if patient develops severe diarrhea, nausea, or vomiting. Prophylaxis with antiemetics and treatment with antidiarrhea medications are recommended ( 5.3 ). • Hepatic Toxicity: Manage by dose reduction or inte

Inrebic Black Box Warning

No black box warning on record for Inrebic

Other warnings & precautions

Inrebic Black Box Warning

No black box warning on record for Inrebic

Other warnings & precautions